Millions of Medicare beneficiaries enrolled in stand-alone prescription drug plans (Part D) are facing a major financial hit in 2027. According to a new analysis by KFF Health News, average monthly premiums for stand-alone drug coverage are projected to jump by 50%, rising from $34 per month in 2026 to $51 per month in 2027.

However, seniors and enrollees can avoid these massive price hikes by taking action before the Medicare Open Enrollment deadline on December 7.

---

Key Cost Increases Facing Medicare Enrollees in 2027

The premium hike isn't the only financial challenge facing Medicare beneficiaries next year. The KFF report highlights several significant structural changes:

• Elimination of Zero-Premium Plans: Over 4.1 million enrollees currently in zero-premium stand-alone drug plans will see automatic rate increases, as no zero-premium plans will be available in 2027.
• Higher Annual Deductibles: The average deductible for stand-alone prescription plans will rise to $643 in 2027 (up from $540 in 2026). For Medicare Advantage drug coverage, deductibles will rise to $489 (up from $360).
• Shift to Coinsurance: More plans are replacing fixed co-payments with percentage-based coinsurance, making out-of-pocket costs less predictable for patients relying on brand-name or specialty medications.

---

How to Save Up to $1,000 on Your Medicare Part D Plan

Health policy experts emphasize that staying passive during this open enrollment period could prove costly.

Real-World Example: Robert Travis Scott, a Medicare recipient from Virginia, received a notice that his AARP-UnitedHealthcare premium was jumping from $39.60 to $121.90 per month. By shopping around online during open enrollment, he found a comparable Humana plan for just $19.30 a month—saving himself over $1,000 for the year.

"With some plans increasing premiums substantially, the stakes are higher this year for people with Medicare stand-alone drug coverage if they sit on the sidelines during open enrollment," warned Juliette Cubanski, Director of the Program on Medicare Policy at KFF.

---

Political Debate: Trump Claims Victory While Premiums Rise

The sharp rate increases come amid heightened political debate over healthcare affordability. President Donald Trump has repeatedly touted his administration's success in lowering drug prices, claiming at recent rallies that the U.S. has negotiated lower prescription costs from pharmaceutical manufacturers under "favored nation" pricing terms.

However, consumer costs depend heavily on individual coverage plans. While stand-alone drug plan rates are soaring, beneficiaries enrolled in Medicare Advantage (MA) plans—which bundle drug coverage with medical insurance—will see much smaller increases, averaging around $9 per month for drug benefits (an increase of less than $2).

---

Why Are Medicare Drug Premiums Increasing?

Industry analysts point to the decision by the Centers for Medicare & Medicaid Services (CMS) to end a temporary three-year premium stabilization subsidy program early.

The pilot program paid subsidies to stand-alone plans in 2025 and 2026 to curb drastic price spikes. CMS Administrator Dr. Mehmet Oz characterized the subsidy program as an "insurance industry bailout," leading to its expiration ahead of the 2027 plan year.

---

Quick Comparison: Stand-Alone Part D vs. Medicare Advantage (2027)

Feature / Metric	Stand-Alone Drug Plans (Part D)	Medicare Advantage Drug Coverage
Total Enrollees	~25 Million	~31 Million
Avg. Monthly Premium	$51 (Up from $34)	$9 for drug portion (Up < $2)
Avg. Annual Deductible	$643	$489
Affected by Zero-Premium Losses	4.1 Million People	Minimal

---

Actionable Advice for Enrollees

If you are one of the 10.4 million Medicare enrollees facing premium hikes in 2027, do not let your policy auto-renew without reviewing it. Visit Medicare.gov or consult a certified SHIP counselor before December 7 to compare alternative plans that cover your specific prescriptions at a lower cost.